Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: August presentation from PTSC home page

I think we do know what the business resolution is. It is the agreement to stop litigating the issue and instead make a business deal in the form of a license agreement. There is NOTHING in any discussion, filing, or other company communication to indicate otherwise, while on the other hand there IS discussion, SEC filings and company communications that indicate JUST THAT.



If you have other information, please provide it, but from the DD I have done, I've been unable to find any "ifs", "ands", "buts", "subject to changes" or other qualifiers that would change the foloowing issued by the company:

On December 18, 2007 all remaining parties to the litigation announced that a resolution was reached in the patent infringement lawsuits. The terms of the settlement included the grant by TPL of rights under the Moore Microprocessor Patent Portfolio to NEC Electronics America, Toshiba, Matsushita and JVC and their respective subsidiaries in the form of license agreements. The parties have agreed that the details of the settlement are confidential.

Share
New Message
Please login to post a reply